V011-9713 Screening compound: N-[(3-methoxyphenyl)methyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide

V011-9713 Screening compound: N-[(3-methoxyphenyl)methyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide
V011-9713 Screening compound: N-[(3-methoxyphenyl)methyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V011-9713
N-[(3-methoxyphenyl)methyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V011-9713

Molecular Formula

C29H30N4O2 (C29 H30 N4 O2)

Compound Name

N-[(3-methoxyphenyl)methyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide

IUPAC name

N-[(3-methoxyphenyl)methyl]-4-{3-[4-(piperidin-1-yl)phenyl]-1H-pyrazol-5-yl}benzamide

SMILES

COc1cccc(CNC(c(cc2)ccc2-c2cc(-c(cc3)ccc3N3CCCCC3)n[nH]2)=O)c1

InChI

InChI=1S/C29H30N4O2/c1-35-26-7-5-6-21(18-26)20-30-29(34)24-10-8-22(9-11-24)27-19-28(32-31-27)23-12-14-25(15-13-23)33-16-3-2-4-17-33/h5-15,18-19H,2-4,16-17,20H2,1H3,(H,30,34)(H,31,32)

InChI Key

HKXVUKQWGAKKOZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19954254

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

466.58

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.900

Distribution Coefficient, logD

5.900

Water Solubility, LogSw

-5.38

Polar Surface Area

57.866

Acid Dissociation Constant (pKa)

12.28

Base Dissociation Constant (pKb)

8.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.10

V011-9713 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V011-9713 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V011-9713?
Check Price and Availability of V011-9713, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V011-9713 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V011-9713
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V011-9713
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V011-9713 available by request